Structure

Physi-Chem Properties

Molecular Weight:  382.18
Volume:  391.714
LogP:  3.781
LogD:  3.244
LogS:  -4.368
# Rotatable Bonds:  5
TPSA:  101.15
# H-Bond Aceptor:  5
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.404
Synthetic Accessibility Score:  4.276
Fsp3:  0.478
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.743
MDCK Permeability:  6.006192506902153e-06
Pgp-inhibitor:  0.002
Pgp-substrate:  0.071
Human Intestinal Absorption (HIA):  0.874
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.03
Plasma Protein Binding (PPB):  98.78141021728516%
Volume Distribution (VD):  0.956
Pgp-substrate:  2.2336347103118896%

ADMET: Metabolism

CYP1A2-inhibitor:  0.118
CYP1A2-substrate:  0.929
CYP2C19-inhibitor:  0.088
CYP2C19-substrate:  0.148
CYP2C9-inhibitor:  0.423
CYP2C9-substrate:  0.928
CYP2D6-inhibitor:  0.527
CYP2D6-substrate:  0.71
CYP3A4-inhibitor:  0.126
CYP3A4-substrate:  0.283

ADMET: Excretion

Clearance (CL):  8.191
Half-life (T1/2):  0.863

ADMET: Toxicity

hERG Blockers:  0.21
Human Hepatotoxicity (H-HT):  0.264
Drug-inuced Liver Injury (DILI):  0.03
AMES Toxicity:  0.078
Rat Oral Acute Toxicity:  0.237
Maximum Recommended Daily Dose:  0.956
Skin Sensitization:  0.924
Carcinogencity:  0.058
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.851

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471913

Natural Product ID:  NPC471913
Common Name*:   DWZZUSPCPXZLJI-UPOJXPCUSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DWZZUSPCPXZLJI-UPOJXPCUSA-N
Standard InCHI:  InChI=1S/C23H26O5/c24-18-7-4-11(8-20(18)26)2-1-3-12-13-5-6-14-16(23(27)28)10-19(25)17-9-15(12)21(13)22(14)17/h4-8,10,12-15,17,19,21-22,24-26H,1-3,9H2,(H,27,28)/t12-,13-,14+,15+,17+,19-,21-,22+/m1/s1
SMILES:  C1C2C(C=C(C3C2C4C1C(C4C=C3)CCCC5=CC(=C(C=C5)O)O)C(=O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3297754
PubChem CID:   90683309
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0001286] Benzenediols
          • [CHEMONTID:0000135] Catechols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33120 beilschmiedia ferruginea Species Lauraceae Eukaryota n.a. n.a. n.a. PMID[24901800]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2796 Individual Protein Apoptosis regulator Bcl-X Homo sapiens Inhibition = 35.0 % PMID[528751]
NPT57 Individual Protein Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens Inhibition = 7.0 % PMID[528751]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471913 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.937 High Similarity NPC471935
0.937 High Similarity NPC471930
0.937 High Similarity NPC471929
0.9213 High Similarity NPC471927
0.8531 High Similarity NPC66894
0.8531 High Similarity NPC8102
0.8504 High Similarity NPC471936
0.8504 High Similarity NPC471925
0.8504 High Similarity NPC471924
0.8504 High Similarity NPC471928
0.8489 Intermediate Similarity NPC471152
0.8438 Intermediate Similarity NPC471926
0.8403 Intermediate Similarity NPC189054
0.8385 Intermediate Similarity NPC470585
0.8345 Intermediate Similarity NPC43353
0.8333 Intermediate Similarity NPC471749
0.8333 Intermediate Similarity NPC86900
0.8322 Intermediate Similarity NPC469447
0.8322 Intermediate Similarity NPC477873
0.8309 Intermediate Similarity NPC30174
0.8286 Intermediate Similarity NPC476699
0.8252 Intermediate Similarity NPC35212
0.8209 Intermediate Similarity NPC15127
0.8207 Intermediate Similarity NPC53520
0.8194 Intermediate Similarity NPC235557
0.8194 Intermediate Similarity NPC310621
0.8194 Intermediate Similarity NPC252133
0.8189 Intermediate Similarity NPC306977
0.8189 Intermediate Similarity NPC242957
0.8189 Intermediate Similarity NPC206414
0.8189 Intermediate Similarity NPC287055
0.8182 Intermediate Similarity NPC473612
0.8182 Intermediate Similarity NPC323601
0.8138 Intermediate Similarity NPC26045
0.8133 Intermediate Similarity NPC105942
0.8133 Intermediate Similarity NPC205392
0.8106 Intermediate Similarity NPC265454
0.8106 Intermediate Similarity NPC34634
0.8099 Intermediate Similarity NPC476393
0.8095 Intermediate Similarity NPC472937
0.8095 Intermediate Similarity NPC472938
0.8095 Intermediate Similarity NPC472936
0.8092 Intermediate Similarity NPC63126
0.8082 Intermediate Similarity NPC271607
0.8082 Intermediate Similarity NPC280717
0.8077 Intermediate Similarity NPC299252
0.8077 Intermediate Similarity NPC277394
0.8077 Intermediate Similarity NPC61062
0.8074 Intermediate Similarity NPC288945
0.8071 Intermediate Similarity NPC18982
0.8071 Intermediate Similarity NPC475346
0.8071 Intermediate Similarity NPC475627
0.8071 Intermediate Similarity NPC475457
0.8069 Intermediate Similarity NPC471971
0.8069 Intermediate Similarity NPC30846
0.8069 Intermediate Similarity NPC469855
0.8069 Intermediate Similarity NPC471972
0.8056 Intermediate Similarity NPC27518
0.8056 Intermediate Similarity NPC82336
0.8056 Intermediate Similarity NPC78987
0.8056 Intermediate Similarity NPC304110
0.8042 Intermediate Similarity NPC182249
0.8042 Intermediate Similarity NPC248287
0.8042 Intermediate Similarity NPC318575
0.8042 Intermediate Similarity NPC234548
0.8031 Intermediate Similarity NPC222084
0.8014 Intermediate Similarity NPC477207
0.8 Intermediate Similarity NPC475454
0.8 Intermediate Similarity NPC475311
0.8 Intermediate Similarity NPC118033
0.8 Intermediate Similarity NPC473680
0.8 Intermediate Similarity NPC473579
0.7986 Intermediate Similarity NPC271494
0.7986 Intermediate Similarity NPC155192
0.7986 Intermediate Similarity NPC473591
0.7985 Intermediate Similarity NPC322332
0.7985 Intermediate Similarity NPC472271
0.7984 Intermediate Similarity NPC148969
0.7972 Intermediate Similarity NPC477592
0.7972 Intermediate Similarity NPC52968
0.7972 Intermediate Similarity NPC231719
0.7959 Intermediate Similarity NPC235195
0.7959 Intermediate Similarity NPC469854
0.7959 Intermediate Similarity NPC469856
0.7959 Intermediate Similarity NPC19862
0.7955 Intermediate Similarity NPC309434
0.7947 Intermediate Similarity NPC475579
0.7947 Intermediate Similarity NPC473773
0.7943 Intermediate Similarity NPC476282
0.7933 Intermediate Similarity NPC472939
0.7931 Intermediate Similarity NPC29599
0.7929 Intermediate Similarity NPC318799
0.7929 Intermediate Similarity NPC198388
0.7929 Intermediate Similarity NPC243305
0.7926 Intermediate Similarity NPC321402
0.7917 Intermediate Similarity NPC116742
0.7917 Intermediate Similarity NPC139243
0.791 Intermediate Similarity NPC98305
0.791 Intermediate Similarity NPC470848
0.791 Intermediate Similarity NPC470849
0.7902 Intermediate Similarity NPC7464
0.7902 Intermediate Similarity NPC90431
0.7902 Intermediate Similarity NPC249817
0.7899 Intermediate Similarity NPC262936
0.7899 Intermediate Similarity NPC30491
0.7895 Intermediate Similarity NPC470214
0.7895 Intermediate Similarity NPC263386
0.7895 Intermediate Similarity NPC141791
0.7895 Intermediate Similarity NPC470215
0.7895 Intermediate Similarity NPC42657
0.7895 Intermediate Similarity NPC109371
0.7891 Intermediate Similarity NPC25491
0.7887 Intermediate Similarity NPC204582
0.7887 Intermediate Similarity NPC194970
0.7883 Intermediate Similarity NPC137416
0.7881 Intermediate Similarity NPC178048
0.7879 Intermediate Similarity NPC175799
0.7879 Intermediate Similarity NPC610
0.7879 Intermediate Similarity NPC200988
0.7879 Intermediate Similarity NPC145023
0.7879 Intermediate Similarity NPC278652
0.7872 Intermediate Similarity NPC25581
0.7872 Intermediate Similarity NPC5419
0.7872 Intermediate Similarity NPC61
0.7872 Intermediate Similarity NPC18074
0.7867 Intermediate Similarity NPC273358
0.7867 Intermediate Similarity NPC298647
0.7862 Intermediate Similarity NPC470616
0.7862 Intermediate Similarity NPC470617
0.7852 Intermediate Similarity NPC471970
0.7852 Intermediate Similarity NPC273798
0.7847 Intermediate Similarity NPC22676
0.7847 Intermediate Similarity NPC475482
0.7847 Intermediate Similarity NPC198621
0.7847 Intermediate Similarity NPC216940
0.7842 Intermediate Similarity NPC234175
0.7838 Intermediate Similarity NPC247221
0.7836 Intermediate Similarity NPC190501
0.7836 Intermediate Similarity NPC318552
0.7832 Intermediate Similarity NPC173569
0.7832 Intermediate Similarity NPC477874
0.7826 Intermediate Similarity NPC71610
0.7826 Intermediate Similarity NPC269598
0.782 Intermediate Similarity NPC203124
0.782 Intermediate Similarity NPC86198
0.7817 Intermediate Similarity NPC155209
0.7817 Intermediate Similarity NPC168799
0.7815 Intermediate Similarity NPC142654
0.7815 Intermediate Similarity NPC470619
0.7815 Intermediate Similarity NPC470618
0.7815 Intermediate Similarity NPC208785
0.7815 Intermediate Similarity NPC145527
0.781 Intermediate Similarity NPC474766
0.781 Intermediate Similarity NPC85565
0.7808 Intermediate Similarity NPC470035
0.7808 Intermediate Similarity NPC9218
0.7808 Intermediate Similarity NPC38473
0.7803 Intermediate Similarity NPC281277
0.78 Intermediate Similarity NPC96930
0.78 Intermediate Similarity NPC32017
0.7794 Intermediate Similarity NPC164947
0.7793 Intermediate Similarity NPC477849
0.7793 Intermediate Similarity NPC469857
0.7793 Intermediate Similarity NPC23667
0.7793 Intermediate Similarity NPC42384
0.7793 Intermediate Similarity NPC50615
0.7793 Intermediate Similarity NPC473779
0.7793 Intermediate Similarity NPC473479
0.7793 Intermediate Similarity NPC5014
0.7793 Intermediate Similarity NPC245760
0.7793 Intermediate Similarity NPC165191
0.7793 Intermediate Similarity NPC91887
0.7793 Intermediate Similarity NPC289358
0.7793 Intermediate Similarity NPC477593
0.7793 Intermediate Similarity NPC51531
0.7793 Intermediate Similarity NPC297797
0.7793 Intermediate Similarity NPC46242
0.7793 Intermediate Similarity NPC157284
0.7793 Intermediate Similarity NPC149773
0.7793 Intermediate Similarity NPC114333
0.7793 Intermediate Similarity NPC28592
0.7792 Intermediate Similarity NPC475484
0.7786 Intermediate Similarity NPC470747
0.7786 Intermediate Similarity NPC120280
0.7785 Intermediate Similarity NPC258856
0.7778 Intermediate Similarity NPC475216
0.7778 Intermediate Similarity NPC475595
0.7778 Intermediate Similarity NPC475145
0.7778 Intermediate Similarity NPC294361
0.7778 Intermediate Similarity NPC473544
0.7778 Intermediate Similarity NPC83663
0.7778 Intermediate Similarity NPC475162
0.7778 Intermediate Similarity NPC266084
0.7778 Intermediate Similarity NPC236520
0.7762 Intermediate Similarity NPC106406
0.7762 Intermediate Similarity NPC11266
0.7762 Intermediate Similarity NPC4982
0.7762 Intermediate Similarity NPC477594
0.7762 Intermediate Similarity NPC471110
0.7762 Intermediate Similarity NPC5310

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471913 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8252 Intermediate Similarity NPD8166 Discontinued
0.797 Intermediate Similarity NPD2932 Approved
0.7929 Intermediate Similarity NPD6663 Approved
0.7899 Intermediate Similarity NPD5736 Approved
0.7836 Intermediate Similarity NPD3019 Approved
0.7591 Intermediate Similarity NPD3092 Approved
0.7556 Intermediate Similarity NPD3091 Approved
0.7538 Intermediate Similarity NPD3021 Approved
0.7538 Intermediate Similarity NPD3022 Approved
0.75 Intermediate Similarity NPD3094 Phase 2
0.7467 Intermediate Similarity NPD6190 Approved
0.7438 Intermediate Similarity NPD8127 Discontinued
0.7419 Intermediate Similarity NPD7028 Phase 2
0.7391 Intermediate Similarity NPD3023 Approved
0.7391 Intermediate Similarity NPD3026 Approved
0.7386 Intermediate Similarity NPD6273 Approved
0.7379 Intermediate Similarity NPD3620 Phase 2
0.7379 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD3025 Approved
0.7372 Intermediate Similarity NPD3024 Approved
0.7319 Intermediate Similarity NPD3095 Discontinued
0.7285 Intermediate Similarity NPD4110 Phase 3
0.7285 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD826 Approved
0.726 Intermediate Similarity NPD825 Approved
0.7208 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD258 Approved
0.7203 Intermediate Similarity NPD257 Approved
0.72 Intermediate Similarity NPD7266 Discontinued
0.7163 Intermediate Similarity NPD9269 Phase 2
0.7143 Intermediate Similarity NPD4140 Approved
0.7133 Intermediate Similarity NPD5408 Approved
0.7133 Intermediate Similarity NPD5406 Approved
0.7133 Intermediate Similarity NPD5404 Approved
0.7133 Intermediate Similarity NPD5405 Approved
0.7124 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD3764 Approved
0.7113 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD37 Approved
0.7099 Intermediate Similarity NPD6234 Discontinued
0.7095 Intermediate Similarity NPD6355 Discontinued
0.7095 Intermediate Similarity NPD230 Phase 1
0.7071 Intermediate Similarity NPD4059 Approved
0.7063 Intermediate Similarity NPD1283 Approved
0.7059 Intermediate Similarity NPD4628 Phase 3
0.7034 Intermediate Similarity NPD9569 Approved
0.7027 Intermediate Similarity NPD943 Approved
0.7025 Intermediate Similarity NPD3455 Phase 2
0.702 Intermediate Similarity NPD9570 Approved
0.7014 Intermediate Similarity NPD1470 Approved
0.7007 Intermediate Similarity NPD2629 Approved
0.698 Remote Similarity NPD555 Phase 2
0.6977 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6975 Remote Similarity NPD4966 Approved
0.6975 Remote Similarity NPD4965 Approved
0.6975 Remote Similarity NPD4967 Phase 2
0.6974 Remote Similarity NPD5762 Approved
0.6974 Remote Similarity NPD5763 Approved
0.6972 Remote Similarity NPD1201 Approved
0.6968 Remote Similarity NPD3300 Phase 2
0.6966 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6959 Remote Similarity NPD8032 Phase 2
0.6959 Remote Similarity NPD259 Phase 1
0.6954 Remote Similarity NPD3299 Clinical (unspecified phase)
0.695 Remote Similarity NPD4626 Approved
0.6941 Remote Similarity NPD7685 Pre-registration
0.6933 Remote Similarity NPD6653 Approved
0.6923 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6918 Remote Similarity NPD9494 Approved
0.6918 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6913 Remote Similarity NPD4060 Phase 1
0.6909 Remote Similarity NPD7199 Phase 2
0.6908 Remote Similarity NPD2935 Discontinued
0.6906 Remote Similarity NPD405 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7228 Approved
0.6897 Remote Similarity NPD1164 Approved
0.6879 Remote Similarity NPD9268 Approved
0.6871 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6867 Remote Similarity NPD274 Approved
0.6867 Remote Similarity NPD275 Approved
0.6866 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6859 Remote Similarity NPD7236 Approved
0.6853 Remote Similarity NPD1281 Approved
0.6849 Remote Similarity NPD5647 Approved
0.6846 Remote Similarity NPD3020 Approved
0.6842 Remote Similarity NPD651 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6839 Remote Similarity NPD7003 Approved
0.6838 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6828 Remote Similarity NPD1876 Approved
0.6824 Remote Similarity NPD9536 Phase 1
0.6824 Remote Similarity NPD9537 Phase 1
0.6815 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6809 Remote Similarity NPD9545 Approved
0.68 Remote Similarity NPD2979 Phase 3
0.6797 Remote Similarity NPD2438 Suspended
0.6779 Remote Similarity NPD6798 Discontinued
0.6772 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6772 Remote Similarity NPD3645 Discontinued
0.6769 Remote Similarity NPD9495 Approved
0.6765 Remote Similarity NPD5844 Phase 1
0.6763 Remote Similarity NPD5951 Approved
0.6761 Remote Similarity NPD5691 Approved
0.6761 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6755 Remote Similarity NPD5735 Approved
0.6748 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6726 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6711 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6711 Remote Similarity NPD3027 Phase 3
0.671 Remote Similarity NPD5958 Discontinued
0.6708 Remote Similarity NPD7458 Discontinued
0.6692 Remote Similarity NPD6647 Phase 2
0.6692 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6691 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6232 Discontinued
0.6667 Remote Similarity NPD2797 Approved
0.6667 Remote Similarity NPD228 Approved
0.6647 Remote Similarity NPD7473 Discontinued
0.6646 Remote Similarity NPD7239 Suspended
0.6645 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6004 Phase 3
0.6645 Remote Similarity NPD6005 Phase 3
0.6645 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6002 Phase 3
0.6643 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6643 Remote Similarity NPD1651 Approved
0.6624 Remote Similarity NPD3400 Discontinued
0.6624 Remote Similarity NPD3750 Approved
0.6623 Remote Similarity NPD7742 Approved
0.6623 Remote Similarity NPD7743 Approved
0.6623 Remote Similarity NPD6233 Phase 2
0.6623 Remote Similarity NPD2799 Discontinued
0.6623 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6622 Remote Similarity NPD4624 Approved
0.662 Remote Similarity NPD5536 Phase 2
0.6619 Remote Similarity NPD6858 Approved
0.6619 Remote Similarity NPD7094 Approved
0.6615 Remote Similarity NPD2859 Approved
0.6615 Remote Similarity NPD2860 Approved
0.6608 Remote Similarity NPD3818 Discontinued
0.66 Remote Similarity NPD7095 Approved
0.6597 Remote Similarity NPD9384 Approved
0.6597 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6597 Remote Similarity NPD9381 Approved
0.6596 Remote Similarity NPD255 Approved
0.6596 Remote Similarity NPD256 Approved
0.6591 Remote Similarity NPD2066 Phase 3
0.6589 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6585 Remote Similarity NPD1934 Approved
0.6581 Remote Similarity NPD2531 Phase 2
0.6577 Remote Similarity NPD2861 Phase 2
0.6571 Remote Similarity NPD5283 Phase 1
0.6569 Remote Similarity NPD74 Approved
0.6569 Remote Similarity NPD9266 Approved
0.6565 Remote Similarity NPD288 Approved
0.6561 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6556 Remote Similarity NPD3268 Approved
0.6554 Remote Similarity NPD8150 Discontinued
0.6549 Remote Similarity NPD9493 Approved
0.6543 Remote Similarity NPD1653 Approved
0.6538 Remote Similarity NPD2346 Discontinued
0.6538 Remote Similarity NPD2934 Approved
0.6538 Remote Similarity NPD2933 Approved
0.6538 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6536 Remote Similarity NPD3657 Discovery
0.6531 Remote Similarity NPD5327 Phase 3
0.6522 Remote Similarity NPD4750 Phase 3
0.6519 Remote Similarity NPD1237 Approved
0.6513 Remote Similarity NPD4062 Phase 3
0.651 Remote Similarity NPD6085 Phase 2
0.651 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6506 Remote Similarity NPD8438 Clinical (unspecified phase)
0.65 Remote Similarity NPD9377 Approved
0.65 Remote Similarity NPD9379 Approved
0.65 Remote Similarity NPD7635 Approved
0.6497 Remote Similarity NPD970 Clinical (unspecified phase)
0.6496 Remote Similarity NPD9264 Approved
0.6496 Remote Similarity NPD2342 Discontinued
0.6496 Remote Similarity NPD9267 Approved
0.6496 Remote Similarity NPD9263 Approved
0.6494 Remote Similarity NPD6353 Approved
0.6494 Remote Similarity NPD7993 Clinical (unspecified phase)
0.649 Remote Similarity NPD7008 Discontinued
0.6489 Remote Similarity NPD844 Approved
0.6488 Remote Similarity NPD6315 Phase 2
0.6481 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6477 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6475 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6471 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6471 Remote Similarity NPD3062 Approved
0.6471 Remote Similarity NPD3061 Approved
0.6471 Remote Similarity NPD1613 Approved
0.6471 Remote Similarity NPD3059 Approved
0.6467 Remote Similarity NPD3882 Suspended
0.6463 Remote Similarity NPD1608 Approved
0.6463 Remote Similarity NPD4380 Phase 2
0.6461 Remote Similarity NPD8434 Phase 2
0.646 Remote Similarity NPD2532 Approved
0.646 Remote Similarity NPD2534 Approved
0.646 Remote Similarity NPD2533 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data